A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants (clinicaltrials.gov) - Aug 18, 2026 - P1 | N=58 | Active, not recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Recruiting ➔ Active, not recruiting
Enrollment closed • Cardiomyopathy • Cardiovascular
|